Cardiologist (Heart Specialist), Advanced Heart Failure and Transplant Specialist
I am passionate about helping heart failure patients author their own story and am honored to be part of such an amazing team at BOB体育. I am an associate professor for the University of Florida鈥檚 Division of Cardiovascular Medicine. I specialize in advanced heart failure, ventricular assist devices and transplantation, while serving as the section chief of heart failure and medical director of the Mechanical Circulatory Support Program at BOB体育. I wear many hats, including the program director of the cardiovascular disease fellowship at UF. I returned to UF in 2013 after serving on faculty at Temple University.
I attended Johns Hopkins University as an undergraduate and obtained my medical degree at West Virginia University School of Medicine, where I was awarded the Van Liere Research Scholarship and the Harak V Dedhia Medical Student Award. Thereafter, I completed my internship and residency at Thomas Jefferson University. I started my training in cardiovascular medicine at UF, followed by an additional fellowship in advanced heart failure and transplantation while serving as the Cardiovascular Cell Therapy Research Network (CCTRN) training scholar.
I am certified by the American Board of Internal Medicine in cardiovascular disease as well as advanced heart failure and transplant cardiology. My current research interests include stem cell therapy in heart failure, ideal strategies for pacemakers and defibrillators in LVAD recipients, interventions to reduce bleeding in LVAD patients and the role of spirituality in medical care. I also stay engaged as a member of the Heart Failure Society of America as well as the International Society for Heart and Lung Transplantation.
Within Gainesville, I am actively engaged in the community, having founded an expense-free medical clinic that received recognition by the Annual Spirit of Gainesville Award in Medicine. In my free time, I enjoy reading fiction, grilling, playing and watching sports, and riding my bicycle.
This is a Phase 2 adaptive, double-blinded, placebo-controlled, randomized, multi-center trial study to evaluate the safety and efficacy of a single dose of AB-1002, administered via antegrade intracoronary artery infusion, in males and females age鈥�
The goal of this international observational study is to learn about the natural history of Danon disease in male patients >8 years of age and female patients
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurancesWhen Freddie Taylor opened his eyes, he was where most people are after intensive surgery: in a hospital bed, being closely monitored by his health care team鈥�
A study led by physicians at the University of Florida College of Medicine鈥檚 Division of Cardiovascular Medicine has shown that survival benefit after鈥�
